Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „study“
Suchtreffer
Begriffe & Kennungen
Benlysta · 4.8 · In a 52-week open-label study in which 25 paediatric patients (10 to 17 years of age) with SLE received subcut
Eintrag öffnenBenlysta · 4.8 · In a 52-week open-label study in which 25 paediatric patients (10 to 17 years of age) with SLE received subcut
Eintrag öffnenBenlysta · 4.8 · In a 52-week open-label study in which 25 paediatric patients (10 to 17 years of age) with SLE received subcut
Eintrag öffnenBenlysta · 4.8 · In a 52-week placebo-controlled study in which 53 patients (6 to 17 years of age) with SLE received Benlysta (
Eintrag öffnenBenlysta · 4.8 · In a 52-week placebo-controlled study in which 53 patients (6 to 17 years of age) with SLE received Benlysta (
Eintrag öffnenBenlysta · 4.8 · In a 52-week placebo-controlled study in which 53 patients (6 to 17 years of age) with SLE received Benlysta (
Eintrag öffnenBenlysta · 4.8 · In a post-marketing SLE study, serious psychiatric events were reported in 1.0 % (20/2002) of patients receivi
Eintrag öffnenBenlysta · 4.8 · In a post-marketing SLE study, serious psychiatric events were reported in 1.0 % (20/2002) of patients receivi
Eintrag öffnenBenlysta · 4.8 · In a post-marketing SLE study, serious psychiatric events were reported in 1.0 % (20/2002) of patients receivi
Eintrag öffnenBenlysta · 4.8 · In a randomised, double-blind, 52-week, post-marketing safety SLE study (BEL115467) which assessed mortality a
Eintrag öffnenBenlysta · 4.8 · In a randomised, double-blind, 52-week, post-marketing safety SLE study (BEL115467) which assessed mortality a
Eintrag öffnenBenlysta · 4.8 · In a randomised, double-blind, 52-week, post-marketing safety SLE study (BEL115467) which assessed mortality a
Eintrag öffnenBenlysta · 4.8 · In the lupus nephritis study, patients were receiving a background of standard therapy (see section 5.1) and t
Eintrag öffnenBenlysta · 4.8 · In the lupus nephritis study, patients were receiving a background of standard therapy (see section 5.1) and t
Eintrag öffnenBenlysta · 4.8 · In the lupus nephritis study, patients were receiving a background of standard therapy (see section 5.1) and t
Eintrag öffnenBenlysta · 4.8 · In the subcutaneous SLE clinical study, which excluded patients with a history of psychiatric disorders, serio
Eintrag öffnenBenlysta · 4.8 · Injection site reactions: In the subcutaneous SLE study, the frequency of injection site reactions was 6.1 % (
Eintrag öffnenBenlysta · 4.8 · Injection site reactions: In the subcutaneous SLE study, the frequency of injection site reactions was 6.1 % (
Eintrag öffnenBenlysta · 4.8 · The adverse reaction profile in paediatric patients is based on one subcutaneous study and one intravenous stu
Eintrag öffnenBenlysta · 4.8 · The adverse reaction profile in paediatric patients is based on one subcutaneous study and one intravenous stu
Eintrag öffnen